Compare Stocks → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CNSX:BLOOTCMKTS:CHEOFOTCMKTS:CHEOYCNSX:ORTH Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLOCannabix TechnologiesC$0.00C$0.40▼C$2.95N/AN/A301,179 shs188,592 shsCHEOFCochlear$209.00$219.60$145.73▼$230.46N/AN/A166 shs110 shsCHEOYCochlear$104.79+0.4%$108.79$73.73▼$114.50$13.73B0.913,377 shs5,673 shsORTHOrtho Regenerative Technologies$0.00$0.37▼$1.00N/AN/AN/A2,500 shs7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLOCannabix Technologies0.00%0.00%0.00%0.00%0.00%CHEOFCochlear0.00%-0.48%-6.68%+8.29%+23.66%CHEOYCochlear+2.12%+0.56%-3.81%+5.99%+25.33%ORTHOrtho Regenerative Technologies0.00%0.00%0.00%0.00%0.00%SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLOCannabix TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ACHEOFCochlearN/AN/AN/AN/AN/AN/AN/AN/ACHEOYCochlearN/AN/AN/AN/AN/AN/AN/AN/AORTHOrtho Regenerative TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLOCannabix TechnologiesN/AN/AN/AN/ACHEOFCochlearN/AN/AN/AN/ACHEOYCochlear1.50ReduceN/AN/AORTHOrtho Regenerative TechnologiesN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLOCannabix TechnologiesN/AN/AN/AN/AN/AN/ACHEOFCochlearN/AN/AN/AN/AN/AN/ACHEOYCochlear$1.32B10.43N/AN/AN/A∞ORTHOrtho Regenerative TechnologiesN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLOCannabix TechnologiesN/AN/A0.00N/AN/AN/AN/AN/AN/ACHEOFCochlearN/A$1.64127.28∞N/AN/AN/AN/AN/ACHEOYCochlearN/AN/A0.0045.76N/AN/AN/AN/AN/AORTHOrtho Regenerative TechnologiesN/AN/A0.00N/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLOCannabix TechnologiesN/AN/AN/AN/AN/ACHEOFCochlear$1.270.61%N/A77.34%N/ACHEOYCochlear$1.161.11%N/AN/AN/AORTHOrtho Regenerative TechnologiesN/AN/AN/AN/AN/ALatest ORTH, BLO, CHEOF, and CHEOY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/16/2024CHEOYCochlear$0.03361%3/21/20243/22/20244/30/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLOCannabix TechnologiesN/ACHEOFCochlear22.47%CHEOYCochlearN/AORTHOrtho Regenerative TechnologiesN/AInsider OwnershipCompanyInsider OwnershipBLOCannabix TechnologiesN/ACHEOFCochlearN/ACHEOYCochlearN/AORTHOrtho Regenerative TechnologiesN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBLOCannabix TechnologiesN/AN/AN/ANot OptionableCHEOFCochlear4,800N/AN/ANot OptionableCHEOYCochlear4,800130.99 millionN/ANot OptionableORTHOrtho Regenerative TechnologiesN/AN/AN/ANot OptionableORTH, BLO, CHEOF, and CHEOY HeadlinesSourceHeadlineThe medtech giants dominating orthopedicsbeckersspine.com - April 22 at 2:41 PMRising Prevalence of Orthopedic Disorders among Aging Population is Driving the Demand for Advanced Bone Screw Systems | Future Market Insights, Inc.finance.yahoo.com - April 22 at 9:41 AMCherokee Nation hosts ARPA-H’s novel osteoarthritis regeneration programcherokeephoenix.org - April 20 at 4:40 PM$33 Million to Truly Regenerate Arthritic Jointsryortho.com - April 19 at 12:41 PM4 recent orthopedic surgery firstsbeckersspine.com - April 18 at 9:02 PMBone Grafts and Substitutes Market Size and Scope, Industry snapshot, Leading Companies and Opportunity Analysis by 2032taiwannews.com.tw - April 17 at 2:05 PMMedical Collagen Market Overview, Latest Trends, Key Players, Revenue, and Forecast 2024 to 2032taiwannews.com.tw - April 17 at 9:05 AMUnlocking the Transformative Potential of Bioactive Glass in Healthcaremsn.com - April 16 at 10:05 AMHow orthopedic surgeon pay compares to 14 other specialtiesbeckersspine.com - April 15 at 7:16 PMAligned Orthopedic Partners taps new CEObeckersspine.com - April 15 at 2:15 PMTable of Experts: Advancements in orthopedic carebizjournals.com - April 12 at 8:20 AMOrthoLite Expands Patent Protection for its Hybrid Technology Linesgbonline.com - April 10 at 5:47 PMAchy joints? Duke researchers get grant for regenerationthecharlottepost.com - April 10 at 12:46 PM4 systems acquiring orthopedic, spine groups in 4 monthsbeckersspine.com - April 10 at 7:37 AM7 top hospitals for both spine and orthopedic researchbeckersspine.com - April 8 at 8:24 PMRational Design of Nanofiber Scaffolds for Orthopedic Tissue Repair and Regenerationmedscape.com - April 6 at 10:33 AMRIT faculty member becomes fellow of the American Institute for Medical and Biological Engineeringrit.edu - April 1 at 8:42 PMKnight Campus director Bob Guldberg to speak at TEDxPortlandaround.uoregon.edu - April 1 at 10:41 AMBone Growth Stimulators Market Exploring the Unseen The Next Frontier of Deep Understanding through Observationtaiwannews.com.tw - April 1 at 10:41 AM'Private equity has the potential to be very beneficial': What we heard in Marchbeckersspine.com - March 29 at 6:01 PMJ&J’s Aldo Denti on digital technology in orthopedicsmedtechdive.com - March 29 at 1:01 PMDuke leads $33M federal project to forward osteoarthritis treatment, rebuild jointsbizjournals.com - March 27 at 7:46 AM3 orthopedic ASC updatesbeckersasc.com - March 27 at 2:46 AMColumbia researchers secure $38.95 million ARPA-H contract to build a living knee replacementmsn.com - March 27 at 2:46 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesThis Underrated Natural Gas Stock Could Rally Double-Digits SoonApril 1, 2024 9:15 AMView This Underrated Natural Gas Stock Could Rally Double-Digits SoonLow Interest Rates Can Help These Commercial Banks Rally HigherApril 2, 2024 11:38 AMView Low Interest Rates Can Help These Commercial Banks Rally HigherIs DraftKings A Good Bet Ahead of Q1 Earnings?March 27, 2024 10:45 AMView Is DraftKings A Good Bet Ahead of Q1 Earnings?3M Spun Off Its Health Division, Is It Still A Buy?April 4, 2024 7:47 AMView 3M Spun Off Its Health Division, Is It Still A Buy?All In: Is MicroStrategy Overleveraging Its Future on Bitcoin? March 26, 2024 6:05 AMView All In: Is MicroStrategy Overleveraging Its Future on Bitcoin? All Headlines Company DescriptionsCannabix TechnologiesCNSX:BLOCannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the work place in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.CochlearOTCMKTS:CHEOFCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.CochlearOTCMKTS:CHEOYCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Ortho Regenerative TechnologiesCNSX:ORTHOrtho Regenerative Technologies Inc., an orthopedic and sports medicine technology company, engages in researching and developing novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a freeze-dried formulation for the treatment of rotator cuff tears; and Ortho-M, a freeze-dried formulation for the treatment of meniscus tears that are under the large animal studies. It also develops Ortho-C, a freeze-dried matrix for the treatment of articular cartilage; and Ortho-V, a freeze-dried biopolymer for the prevention of osteoarthritis pain that are under the feasibility studies. The company was incorporated in 2015 and is headquartered in Kirkland, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
